Viewing Study NCT05794659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:52 PM
Ignite Modification Date: 2026-01-26 @ 6:36 AM
Study NCT ID: NCT05794659
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-07-20
First Post: 2023-03-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer
Sponsor: Aston Sci. Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer vaccine View
None phase 2 study View
None Advanced ovarian cancer View
None homologous-recombination proficient (HRP) View